Jane Osbourn, Founder of Alchemab Therapeutics

Jane Osbourn is the founder of Alchemab Therapeutics. Alchemab Therapeutics has raised $82M, latest Series A $82M (2021). Biotech · London, UK.

About Jane Osbourn

Jane Osbourn is the founder of Alchemab Therapeutics. Alchemab Therapeutics operates in Biotech and is based in London, UK. Alchemab Therapeutics has raised $82M, latest Series A $82M (2021). Backers on record include Houman Ashrafian, Nikola Trbovic, SV Health Investors.

Jane Osbourn at a glance

Company
Alchemab Therapeutics
Industry
Biotech
Location
London, UK
Total raised
$82M
Investors on record
Houman Ashrafian, Nikola Trbovic, SV Health Investors

Frequently asked about Jane Osbourn

Who is Jane Osbourn?
Jane Osbourn is the founder of Alchemab Therapeutics. Full profile, funding history and background on StartupFundraising.com.
What company did Jane Osbourn found?
Jane Osbourn founded Alchemab Therapeutics, a Biotech company based in London, UK.
How do I contact Jane Osbourn?
Verified contact routes, background and funding history for Jane Osbourn are available on the StartupFundraising.com founder profile.

This founder profile draws on disclosed rounds, filings and investor records in the StartupFundraising database and is updated as new funding is recorded. Founders raising now use profiles like this one to study comparable Biotech journeys in London — who backed them, at what stage, and how much they raised.

More Biotech founders (40)

Browse related founder lists (6)

Full founder directory · Investor directory · Company funding database · Fundraising library

Resources
Join free
Sign Out Dashboard

The Startup Fundraising Platform

Raise funds for your startup

Find the right investors and get real replies — instantly, powered by AI.

  • AI-scored pitch deck
  • Matched investor list
  • Personalized outreach drafts
Join for free

Takes 30 seconds · No credit card · Cancel anytime

See it in action ↓
  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
  • All
  • Seed & Pre-Seed
  • Series A & B
  • Fintech
  • SaaS & Dev Tools
  • Consumer & Social
  • Marketplace & Frontier
  • Mistakes to Avoid
  • Checklist
  • How to Send
  • Design
  • Length
  • Order
  • Storytelling
  • Investor Q&A
  • One-Pager
  • Email Templates
  • Data Room
  • Investor Update
  • Term Sheet
  • SAFE vs Priced
  • Due Diligence
  • Timeline
  • Metrics
  • Valuation
  • Cap Table
  • Pipeline
  • Board
  • Objections
  • References
  • Closing
  • Bridge Round
  • Down Round
  • Secondary Sale
  • Investor Rejection
  • First Meeting
  • Second Meeting
  • Partner Meeting
  • Post-Mortem
  • Update Cadence
  • Angel Round
  • Option Pool Shuffle
  • Fundraise Pause
  • Vetting VCs
  • First 90 Days
  • First Board Meeting
  • Reference Calls
  • NDA Template
  • Bylaws Template
LibraryPitch Deck Examples

Slide-by-slide guide

 

  • Library
  • Articles
  • Pitch Decks
  • Videos
  • Shorts
  • Profiles
  • Visuals
  • Questions
  • Ask
LibraryArticles

•By Alejandro Cremades